Ritscher D, Russi E W
Abteilung Pneumologie, Universitätsspital Zürich.
Ther Umsch. 1999 Mar;56(3):142-6. doi: 10.1024/0040-5930.56.3.142.
The dysbalance between proteolytic neutrophil elastase and its endogeneous inhibitor seems to be a pathogenetic key mechanism in the origin of pulmonary emphysema (elastase-antielastase hypothesis). This hypothesis is supported by the observation, that low serum levels of alpha 1-antitrypsin can be observed in smokers with premature pulmonary emphysema. alpha 1-proteinase inhibitor is an acute phase protein with known structural and moleculargenetic aspects, which is synthesized by the liver and reaches the lung by the circulation. Its role is the inactivation of excessive neutrophil elastase in the pulmonary parenchyma, which is liberated during inflammation and destroys elastin and other components of extra-cellular connective tissue matrix. This is an overview on epidemiology, clinical aspects, genetics and molecular biology of this particular disease which was described in 1963.
蛋白水解性中性粒细胞弹性蛋白酶与其内源性抑制剂之间的失衡似乎是肺气肿发病机制中的关键机制(弹性蛋白酶-抗弹性蛋白酶假说)。这一假说得到了以下观察结果的支持:在患有早发性肺气肿的吸烟者中可观察到血清α1-抗胰蛋白酶水平较低。α1-蛋白酶抑制剂是一种具有已知结构和分子遗传学特征的急性期蛋白,由肝脏合成并通过血液循环到达肺部。其作用是使肺实质中过量的中性粒细胞弹性蛋白酶失活,这种弹性蛋白酶在炎症过程中释放出来,会破坏弹性蛋白和细胞外结缔组织基质的其他成分。这是对1963年描述的这种特殊疾病的流行病学、临床方面、遗传学和分子生物学的概述。